Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue
Published
The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago.
Full ArticlePublished
The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago.
Full ArticleThe experimental Regeneron antibody treatment used to treat President Trump for COVID-19 was developed using cells originally..
US President Donald Trump has been treated with an anti-COVID-19 drug developed with cells derived from fetal tissue. He called it..